West German Study Group
Clinical trials sponsored by West German Study Group, explained in plain language.
-
Could a pill replace chemo for some breast cancer patients?
Disease control OngoingThis study tests if a combination of ribociclib (a targeted pill) and hormone therapy works better than standard chemotherapy for women with a common type of early breast cancer (HR+/HER2-). About 1,684 women with intermediate-risk disease are taking part. The goal is to see whic…
Phase: PHASE3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a targeted pill keep High-Risk breast cancer at bay?
Disease control OngoingThis phase 3 trial studies whether adding the drug abemaciclib (Verzenios) to standard hormone therapy helps prevent breast cancer from coming back in 1,260 women with high-risk, HR+/HER2- early breast cancer. Participants have already completed initial treatments like surgery or…
Phase: PHASE3 • Sponsor: West German Study Group • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC